This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Enbrel
  • /
  • A Phase 3, Multi Site, Randomized, Double Blind, P...
Clinical trial

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Of The Efficacy And Safety Of 2 Oral Doses Of CP- 690,550 And 1 Subcutaneous Dose Of Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Read time: 2 mins
Last updated:1st Nov 2010
Identifier: NCT01241591
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest